Lifeward Ltd. - מחיר ריאלי לרכישת החברה במלואה LFWD

Revenue growth for ReWalk Robotics Ltd. (LFWD), a developer of exoskeletons, is being driven by the expansion of Medicare programs. However, business success depends on the willingness of clinics to implement robotics and new insurance reimbursement rules. This chart illustrates an Enterprise Value of 18.07, while operating losses render cash flows unstable, as reflected in the daily price action.

Systemic inertia in medical centers, driven by the costs of training personnel to operate ReWalk Robotics Ltd. (LFWD) exoskeletons, generates a steady cash flow from services. This market capitalization plus net debt digitizes the cost of a full business buyout by summing the value of shares and liabilities minus liquidity, allowing an investor to objectively assess the company's real price and avoid purchasing overvalued assets.